11 results about "Cytoprotective Agent" patented technology

The invention provides an organ perfusate and a preparation method thereof. The Na ion concentration of the organ perfusate is 110-130 mmol / L, and the K ion concentration of the organ perfusate is 20-30 mmol / L; the organ perfusate is prepared from 0.024 mmol / L to 0.036 mmol / L of a colloid osmotic pressure substance, 100 mmol / L to 103 mmol / L of an impermeable substance, 0.001 mmol / L to 0.025 mmol / L of a cell protecting agent, 23 mmol / L to 38 mmol / L of a buffering substance, 3.015 mmol / L to 8.06 mmol / L of calcium and magnesium inorganic salt, 2.5 mmol / L to 6.5 mmol / L of an antioxidant and the balance of an energy substrate. Wherein the molar osmotic pressure of the organ perfusate is 290-320 mOsm / kg, and the viscosity of the organ perfusate at a preset temperature is lower than 2.0 cP; the colloid osmotic pressure substance is Pluronic F-68; and the cell protective agent is thyroxine.

The invention relates to the technical field of biology, and particularly discloses a supercooled cell preserving fluid as well as a preserving method and application thereof. The preserving fluid is mainly prepared from RPX basic cell preserving fluid, an energy substrate, a calcium ion channel blocker, a Na < + > / H < + > exchange channel inhibitor, a colloid impermeable cell protective agent, a cell apoptosis inhibitor, an antioxidant, an inflammation inhibitor, a colloid osmotic pressure regulator, a PH regulator and the like according to a certain proportion. According to the preservation method, the cells are preserved under the subcooling condition of-1 DEG C to-7 DEG C, the cell metabolism rate is reduced to the maximum extent, meanwhile, structural and functional damage caused by freezing to the cells is eliminated, and the effect that the survival rate of the recovered cells exceeds 80% after the cells are preserved for more than 18 months under the non-freezing condition is achieved; the application opens up a way for long-term non-freezing preservation of special functional cells of cells and genetic engineering and clinical cell treatment products, provides an effective method, and lays a foundation for starting a new stage of non-freezing long-term preservation of the cells.

The present invention aims to provide a cytoprotective agent against ferroptosis that contains DHMBA as an active ingredient, by verifying the effect of DHMBA in suppressing ferroptotic cell death using DN model mice and human renal tubular cells HK-2, for each useful agent containing DHMBA as an active ingredient. [Solution] The present invention provides a cell agent for ferroptosis that has a cytoprotective effect against ferroptosis, comprising 3,5-dihydroxy-4-methoxybenzyl alcohol as an active ingredient.

The invention belongs to the technical field of biological medicine, and provides an iron-based nanodot capable of guiding MRI and delivering medicine and a preparation method and application of the iron-based nanodot. The iron-based nanodot is used as a chemotherapeutic drug carrier, and is prepared from a cell protective agent amifostine (AT) and key nutritional metal iron ions (Fe < 3 + >) for inducing ferroptosis through a supramolecular self-assembly technology. The iron-based nanodot can efficiently load the chemotherapeutic drug, improves pharmacokinetic behaviors such as short in-vivo circulation period and fast metabolism of the chemotherapeutic drug, accurately delivers the chemotherapeutic drug to a tumor site, and improves the drug effect of the chemotherapeutic drug; in addition, the iron-based nanodots can realize efficient ferroptosis treatment under the guidance of MRI to induce immunogenic cell death and inhibit growth, metastasis and diffusion of tumor cells.

This invention provides a cell culture additive composition for preventing antibody disulfide bond reduction and its application, relating to the biopharmaceutical field. It comprises the following raw materials: a redox regulator, a metal ion chelator, an antioxidant, an adjuvant, and a cell protectant. This invention inhibits antibody disulfide bond reduction from multiple aspects through the synergistic effect of the redox regulator, metal ion chelator, antioxidant, and buffer. Specifically, the redox regulator maintains a suitable redox potential, the metal ion chelator removes harmful metal ions, the antioxidant removes free radicals, and the buffer maintains pH stability. The components work together synergistically to enhance the effect.

The application discloses an electroporation transfection protection fluid suitable for abalone embryo cell gene editing and application thereof, and belongs to the technical field of gene editing. The electroporation transfection protection fluid comprises a basic fluid and a cell protection agent; the basic fluid comprises NaCl, MgSO4, CaCl2, KCl, NaHCO3, NaBr, K2HPO4, glucose and glutathione; and the cell protection agent comprises polyethylene glycol 400. The electroporation transfection protection fluid can significantly reduce the deformity rate and mortality rate of abalone cells after electroporation technology, improve the gene transfection and gene editing efficiency, and reduce the cost of gene editing experiments, thereby laying a foundation for accelerating marine biological research and promoting environmental protection, species conservation and aquaculture.

This invention discloses a culture medium and process for alleviating ammonium accumulation in cells. The concentrations of the substances added to the culture medium are as follows: 2 g / L glutamate, 0 g / L glutamine, 2 g / L aspartic acid, 2 g / L asparagine, 1 g / L serine, 1 g / L pyruvate, 0.5 g / L α-ketoglutarate, 0.5 g / L oxaloacetic acid, 0.5 g / L proline, 0 g / L glucose, 8 g / L galactose, and 0.1% glycerol. Compared with the prior art, the advantages of this application are: this method mainly achieves the purpose of maintaining cell viability and reducing the cell metabolic byproduct ammonium ions by adjusting the proportion of substances related to cell metabolic pathways and adding additional cell protectants; using the optimized culture medium of this invention, the cell viability can be increased from 42.38% to 95.21% and the ammonium ion concentration can be reduced from 6.308 mM to 0.914 mM by day 7.

The invention relates to the technical field of biology, and discloses a recovery liquid for improving recovery efficiency and vitality of organoids, which comprises a metal ion chelating agent, a dissociation agent and a cell protective agent. According to the recovery liquid, matrigel is mildly disintegrated through cooperation of the metal ion chelating agent and the dissociation agent, the organoid can be separated from the matrix within 30 minutes, and the recovery rate of the organoid reaches 90% or above and is far higher than that of a pure mechanical blowing method; the dissociation agent is used for replacing pancreatin and other strong digestive enzymes, and is matched with the cell protective agent, so that the survival rate of the recovered organoid is greater than or equal to 95%, the three-dimensional structure and the intercellular connection are kept complete, and the biological function is real; all the components are clear, the batch is stable, the operation is simple and convenient, the storage is convenient, the culture medium is suitable for passage, collection, downstream cell counting, molecular detection, immunofluorescence, living cell imaging and the like of various sources of organoids such as gastrointestinal tracts, livers and lungs, and the standardization and repeatability of organoid culture are remarkably improved.

[Problem] The purpose of the present invention is to provide, as each useful agent that contains DHMBA as an active ingredient, a cytoprotective agent against ferroptosis, the cytoprotective agent containing DHMBA as an active ingredient and having a cytoprotective action against ferroptosis by verifying the effect of suppressing ferroptosis cell death of DHMBA using a DN model mouse and a human renal tubular cell HK-2. [Solution] The present invention provides a cell agent against ferroptosis, the cell agent containing 3,5-dihydroxy-4-methoxybenzyl alcohol as an active ingredient and having a cytoprotective action against ferroptosis.

The invention provides a lipid composition, a culture medium and a method for multidirectionally differentiating human induced pluripotent stem cells to three germ layers and application of the lipid composition. The culture medium comprises a basic culture medium as well as a lipid combination, a cell protective agent, an antioxidant, a cell nutrition supplement, a non-essential amino acid supplement, an insulin-transferrin-selenium-ethanolamine supplement, a reducing agent, an anti-apoptosis agent and the like which are added into the basic culture medium, the method sequentially comprises the steps of embryoid body formation, multidirectional differentiation and re-paving and adherent culture. According to the lipid composition, the culture medium and the method, the embryoid body with regular form and high yield can be efficiently and stably formed, so that the differentiation of the induced pluripotent stem cells to the trigerm cells is promoted, and the expression level of the trigerm characteristic markers is remarkably improved. The method shows good repeatability and applicability in different induced pluripotent stem cell lines, and provides a reliable tool for standardized evaluation and downstream application of stem cell multidirectional differentiation potential.

The present application relates to a kind of mesenchymal stem cell digestive juice and its preparation method and application, belong to stem cell technical field.The mesenchymal stem cell of the present application includes trypsin, cell protective agent and phosphate buffer solution, in the digestive juice, the concentration of trypsin is 0.02-0.07wt%, the concentration of cell protective agent is 2.01005-7.05005wt%;The cell protective agent is the mixed solution of vitamin C, epidermal growth factor and serum albumin solution.The mesenchymal stem cell digestive juice of the present application, low concentration trypsin is combined with cell protective agent, can be fully dissociated outside mesenchymal stem cell while ensuring that cell is not over-digested by trypsin, and need not to add other reagent to terminate digestion, avoid other animal source serum to contaminate mesenchymal stem cell, reduce the culture cost of mesenchymal stem cell, simplify the culture step of mesenchymal stem cell.